BBC presenter died after suffering blood clots following AstraZeneca jab, family says

Newcastle coroner to determine cause of death

The award-winning BBC radio presenter Lisa Shaw died on 21 May, 2021.
The award-winning BBC radio presenter Lisa Shaw died on 21 May, 2021.

A 44-year-old BBC radio presenter died last week after experiencing blood clots following her AstraZeneca jab, her family has said.

Lisa Shaw, who worked for BBC Newcastle, passed away on Friday at the Royal Victoria Infirmary, Newcastle.

The mother-of-one’s death was announced on Sunday, leading to scores of tributes from her colleagues and listeners.

Rik Martin, who worked with her, described her as “a trusted colleague, a brilliant presenter, a wonderful friend, and a loving wife and mum”.

“She loved being on the radio and was loved by our audiences. We’ve lost someone special who meant a great deal to a great many people.”

Her family said she developed “severe headaches” a week after having her vaccine, before falling seriously ill and being treated for blood clots.

They added: “We are devastated and there is a Lisa-shaped hole in our lives that can never be filled. We will love and miss her always.

“It’s been a huge comfort to see how loved she was by everyone whose lives she touched, and we ask for privacy at this time to allow us to grieve as a family.”

The BBC confirmed that a coroner in Newcastle will investigate her death, after one of the potential causes was listed as a “complication of AstraZeneca Covid-19 virus vaccination”.

A link has been made between the vaccine and extremely rare forms of blood clots. To date, almost 35 million AstraZeneca doses have been administered in England, with 332 reported cases of major thrombosis and 58 reported deaths.

As a result of this, all under-40s in the UK are being offered alternative Covid-19 vaccines.

For people in their 40s, the risk of clotting is estimated to be one in 100,000 and the chance of dying is around one in a million.

Consequently, the British medical regulator MHRA has said the advantages of the jab outweigh the risks for most age groups.

On Thursday, German scientists announced that they may have found the cause of blood clots linked to the AstraZeneca and Johnson & Johnson vaccines.

Additional reporting from PA

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in